Madrid, Dec. 22, 2021 /PRNewswire/ -- PharmaMar (MSE: PHM) has announced today a new license and commercialization agreement with the Eczacıbaşı Pharmaceuticals Marketing Co. to commercialize the anticancer drug lurbinectedin in Turkey.
Under the terms of the agreement, PharmaMar will receive a non-disclosed